Á lódáil...
Single center experience suggests donor lymphocyte infusion may promote long-term survival in children with high-risk acute lymphoblastic leukemia
BACKGROUND: Donor lymphocyte infusion (DLI) is often used to treat leukemic relapse after hematopoietic cell transplantation (HCT). However, the relationship between outcomes and distinct DLI cellular composition has not been previously reported. Additionally, there is limited published data on effi...
Na minha lista:
Foilsithe in: | Pediatr Blood Cancer |
---|---|
Main Authors: | , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
2019
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6754268/ https://ncbi.nlm.nih.gov/pubmed/31368194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.27950 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|